ConductScience.org, home

Paper23010705

Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma.

Sutton LM and 6 others. Am J Clin Pathol, 2012. Cited by 84 papers, by iCite.

Cite this record

ConductScience Library. Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma. Papers, record 23010705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23010705

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma.
PubMed
Journal
Am J Clin Pathol
PubMed
Year
2012
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
84
iCite
Relative citation ratio, by iCite
2.13
iCite
Revised in PubMed
2026-01-28
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sutton LMLisa M
2Cao DDengfeng
3Sarode VVenetia
4Molberg KHKyle H
5Torgbe KKwame
6Haley BBarbara
7Peng YYan

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Breast NeoplasmsMajor topic
Erb-b2 Receptor Tyrosine KinasesMajor topic
Receptors, AndrogenMajor topic
Receptors, EstrogenMajor topic
Receptors, ProgesteroneMajor topic
Biomarkers, Tumor
Female
Humans
Ki-67 Antigen
Neoplasm Metastasis
Prognosis

Source PubMed

Download CSV of topics

Cited by61

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.

PMIDTitleJournalYearIn PapersSource
42094881Glucose metabolic reprogramming: a novel strategy to enhance radiotherapy response to triple-negative breast cancer.Front Public Health2026https://conductscience.org/library/papers/42094881PubMed
41948492Assessing the prognostic role of androgen receptor expression in non-metastatic triple-negative breast cancer.Front Oncol2026https://conductscience.org/library/papers/41948492PubMed
41079087Case Report: Androgen receptor-positive, locoregionally advanced breast cancer in a transgender man and an update on breast cancer management in a gender-diverse patient population.Front Oncol2025https://conductscience.org/library/papers/41079087PubMed
40862714Identification of Epigenetic Regulatory Networks of Gene Methylation-miRNA-Transcription Factor Feed-Forward Loops in Basal-like Breast Cancer.Cells2025https://conductscience.org/library/papers/40862714PubMed
40685652Androgen receptor expression in triple negative breast cancer: an Algerian population study.Libyan J Med2025https://conductscience.org/library/papers/40685652PubMed
40448099C/EBPβ increases tumor aggressiveness by enhancing KIFC1 expression in androgen receptor negative triple negative breast cancer.Cell Commun Signal2025https://conductscience.org/library/papers/40448099PubMed
39851328Dual Functions of Androgen Receptor Overexpression in Triple-Negative Breast Cancer: A Complex Prognostic Marker.Bioengineering (Basel)2025https://conductscience.org/library/papers/39851328PubMed
39588561Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis.Mol Cancer Ther2025https://conductscience.org/library/papers/39588561PubMed
39555351Analyzing Androgen Receptor Expression in Breast Cancer: Insights into Histopathological Parameters and Hormone Receptor Status Among Indian Women.Indian J Surg Oncol2024https://conductscience.org/library/papers/39555351PubMed
39421321Expression of nuclear receptors and glucose metabolic pathway proteins in sebaceous carcinoma: Androgen receptor and monocarboxylate transporter 1 have a key role in disease progression.Oncol Lett2024https://conductscience.org/library/papers/39421321PubMed
39399414Triple-Negative Breast Cancer: Tumor Immunogenicity and Beyond.Int J Breast Cancer2024https://conductscience.org/library/papers/39399414PubMed
39020535Triple-negative breast cancer: from classical clinicopathological features to androgen receptor profile.Rom J Morphol Embryol2024https://conductscience.org/library/papers/39020535PubMed
38741650Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC).Indian J Surg Oncol2024https://conductscience.org/library/papers/38741650PubMed
38374890Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer.J Bone Oncol2024https://conductscience.org/library/papers/38374890PubMed
38130277Androgen Receptor Expression in ER and PR Negative Breast Cancer-A Study from a Tertiary Hospital in Northern India.South Asian J Cancer2023https://conductscience.org/library/papers/38130277PubMed
38058819Advancing breast cancer subtyping: optimizing immunohistochemical staining classification with insights from real-world Taiwanese data.Am J Cancer Res2023https://conductscience.org/library/papers/38058819PubMed
38003261Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers.Int J Mol Sci2023https://conductscience.org/library/papers/38003261PubMed
37817975Prevalence of Androgen Receptor in Invasive Breast Cancer and Its Association with Clinicopathologic Features in East Azarbaijan Province of Iran: A Cross-Sectional Study.Int J Hematol Oncol Stem Cell Res2023https://conductscience.org/library/papers/37817975PubMed
37438515Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study.Breast Cancer Res Treat2023https://conductscience.org/library/papers/37438515PubMed
37435469SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients.Endocr Oncol2022https://conductscience.org/library/papers/37435469PubMed

See all 61 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AR367PubTator's text mininghttps://conductscience.org/library/genes/367

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23010705

GET https://conductscience.org/api/papers/v1/23010705/cited_by?page=2